<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04344899</url>
  </required_header>
  <id_info>
    <org_study_id>19-0964</org_study_id>
    <nct_id>NCT04344899</nct_id>
  </id_info>
  <brief_title>Pediatric Oncology Recovery Trial After Surgery</brief_title>
  <acronym>PORTS</acronym>
  <official_title>Pediatric Oncology Recovery Trial After Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pediatric Oncologic Recovery Trial After Surgery (PORTS) trial is an investigator-initiated,
      multicenter, multidisciplinary prospective case-control study of the implementation of an
      Enhanced Recovery After Surgery (ERAS) protocol at five tertiary-care pediatric hospitals in
      pediatric patients undergoing abdominal or retroperitoneal surgical resections for cancer. A
      pilot phase will determine characteristics of a successful protocol implementation and an
      exploratory phase plans to examine adherence, objective patient outcomes, and
      patient-reported outcomes. After completing primary enrollment, this collaborative will
      continue to enroll patients in the shared data registry and continue to refine the underlying
      ERAS protocol developed for this project.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two arms:

      Historical patients ERAS patients

      Number of patients: 288

      Primary outcome

      Â· Number of 90-day complications by Clavien-Dindo classification

      Secondary outcome(s):

        -  Adherence to ERAS protocol items with # of items achieved (out of 20)

        -  Length of stay

        -  Re-admissions within 90 days

        -  Re-operations within 90 days

        -  Number of visits to the emergency room within 90 day period

        -  Minimum, mean, maximum daily pain score during first 7 days after surgery

        -  Mean daily IV morphine equivalents (mg/kg) usage during first 7 days after surgery

             -  recurrence free survival (months)

             -  overall survival (months)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 23, 2019</start_date>
  <completion_date type="Anticipated">July 2025</completion_date>
  <primary_completion_date type="Anticipated">July 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>90 Days</target_duration>
  <primary_outcome>
    <measure>Number of 90-day complications by Clavien-Dindo classification</measure>
    <time_frame>90 Days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Adherence issues to ERAS protocol items with # of items achieved (out of 20)</measure>
    <time_frame>90 Days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>90 Days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Re-admissions within 90 days</measure>
    <time_frame>90 Days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Re-operations within 90 days</measure>
    <time_frame>90 Days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of visits to the emergency room within 90 day period</measure>
    <time_frame>90 Days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS daily pain score during first 7 days after surgery</measure>
    <time_frame>90 Days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean daily IV morphine equivalents (mg/kg) usage during first 7 days after surgery</measure>
    <time_frame>90 Days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence free survival (months)</measure>
    <time_frame>90 Days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival (months)</measure>
    <time_frame>90 Days</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">288</enrollment>
  <condition>Pelvic Cancer</condition>
  <arm_group>
    <arm_group_label>Historical</arm_group_label>
    <description>Retrospective Review</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ERAS Patients</arm_group_label>
    <description>Prospective Review</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <description>Enhanced Recovery After Surgery protocol at five tertiary-care pediatric hospitals in pediatric patients undergoing abdominal or retroperitoneal surgical resections for cancer.</description>
    <arm_group_label>ERAS Patients</arm_group_label>
    <arm_group_label>Historical</arm_group_label>
    <other_name>ERAS Protocol</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric patients undergoing urological surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  - Patients undergoing operations at a pediatric hospital setting aged 1 month or older

          -  Parents of patients undergoing operations at pediatric hospital settings aged 1 month
             or older

          -  Undergoing urologic reconstruction, ureteral operations, pyeloplasty, intraabdominal
             on-cologic resections, urachal remnant excision, bariatric operations, pectus surgery,
             ap-pendicitis, orthopedic or neurosurgical operations and inflammatory bowel disease
             proce-dures

          -  Providers of patients undergoing surgery in pediatric settings

        Exclusion Criteria: Less than 1 month in age

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyle Rove, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Childrens Hospital Colorado</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amandla Atilano-Roque</last_name>
    <phone>720-777-1497</phone>
    <email>AmandlaAtilano-Roque@childrenscolorado.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyle Rove, MD</last_name>
      <phone>720-777-5084</phone>
      <email>kyle.rove@childrenscolorado.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Jude Children's Research Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liza Emanus</last_name>
      <email>liza.emanus@stjude.org</email>
    </contact>
    <investigator>
      <last_name>Sara Mansfield, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alberta Children's Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Lam</last_name>
      <email>jennifer.yk.lam@albertahealthservices.ca</email>
    </contact>
    <investigator>
      <last_name>Paul Beaudry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 9, 2020</study_first_submitted>
  <study_first_submitted_qc>April 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2020</study_first_posted>
  <last_update_submitted>July 9, 2020</last_update_submitted>
  <last_update_submitted_qc>July 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pelvic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

